These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 6361325

  • 41. [Clinical use of cefroxadine in dentistry and oral surgery].
    Kikuta T, Masuda N, Kinebuchi T, Takarada H.
    Jpn J Antibiot; 1983 Aug; 36(8):2017-28. PubMed ID: 6655824
    [Abstract] [Full Text] [Related]

  • 42. Cephradine and cephalexin in the treatment of children with bacterial pneumonia.
    Alban J, Caloza DL.
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):539-45. PubMed ID: 241608
    [No Abstract] [Full Text] [Related]

  • 43. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K, Fukayama S, Nishimura Y, Nishike A, Oda S, Sato S, Matsumoto Y, Ikegami R, Yokota N, Tanaka S.
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [Abstract] [Full Text] [Related]

  • 44. [Therapeutic evaluation of an ampicillin suppository (KS-R1) used against acute suppurative otitis media in children: a comparison with an oral preparation].
    Baba S, Wada K, Maseki T, Murai K, Kinoshita H, Yokota A, Tsukiyama M, Hondoh J, Hashiba M, Fukuoka Y.
    Jpn J Antibiot; 1983 Jul; 36(7):1973-94. PubMed ID: 6361321
    [Abstract] [Full Text] [Related]

  • 45. Ceftazidime in the treatment of chronic suppurative otitis media in children.
    Lautala P, Vare M, Vuorinen O, Kaar ML.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():365-7. PubMed ID: 6352646
    [Abstract] [Full Text] [Related]

  • 46. Efficacy and safety of ofloxacin and its combination with dexamethasone in chronic suppurative otitis media. A randomised, double blind, parallel group, comparative study.
    Panchasara A, Singh A, Mandavia D, Jha S, Tripathi C.
    Acta Otorhinolaryngol Ital; 2015 Feb; 35(1):39-44. PubMed ID: 26015650
    [Abstract] [Full Text] [Related]

  • 47. Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study.
    Takahashi M, Iwasaki S, Kawano T, Ikoma R, Oka S, Terasaki M, Sato H, Kariya S, Takahashi H.
    Auris Nasus Larynx; 2023 Aug; 50(4):521-533. PubMed ID: 36599786
    [Abstract] [Full Text] [Related]

  • 48. Occurrence of otitis media in children and assessment of treatment options.
    Nwokoye NN, Egwari LO, Olubi OO.
    J Laryngol Otol; 2015 Aug; 129(8):779-83. PubMed ID: 26072993
    [Abstract] [Full Text] [Related]

  • 49. Topical ciprofloxacin versus topical gentamicin for chronic otitis media.
    Nawasreh O, Fraihat A.
    East Mediterr Health J; 2001 Aug; 7(1-2):26-30. PubMed ID: 12596948
    [Abstract] [Full Text] [Related]

  • 50. [Use of lysozyme for the treatment of suppurative otitis media].
    Shaikhov ZSh, Usenko MM, Seleskerova AF.
    Zh Ushn Nos Gorl Bolezn; 1979 Aug; (2):33-6. PubMed ID: 373295
    [No Abstract] [Full Text] [Related]

  • 51. [Clinical evaluation of cefroxadine in bacterial infections of the eye].
    Ooishi M, Nagai S, Nishizuka K, Tanaka R, Takagi K, Hara J, Tanaka Y, Ichihashi K, Hirose Y, Akashi N.
    Jpn J Antibiot; 1983 Sep; 36(9):2635-64. PubMed ID: 6655872
    [Abstract] [Full Text] [Related]

  • 52. [Clinical evaluation of long-acting preparation of cephalexin (S-6436) in the treatment of acute tonsillitis and acute otitis media--a double blind study (author's transl)].
    Baba S, Ito H, Tsukiyama M, Iwata S, Nishimura T.
    Kansenshogaku Zasshi; 1977 Jun; 51(6):286-302. PubMed ID: 411841
    [No Abstract] [Full Text] [Related]

  • 53. [Clinical use of Cefroxadine in oral medicine].
    Salvato A, Calderini A, Zambruno E.
    Dent Cadmos; 1985 Sep 30; 53(14):115-6, 119-20, 123-4. PubMed ID: 3869543
    [No Abstract] [Full Text] [Related]

  • 54. Preoperative therapeutic considerations in chronic suppurative otitis media.
    Papastavros T, Giamarellou H, Varlejides S.
    Laryngoscope; 1989 Jun 30; 99(6 Pt 1):655-9. PubMed ID: 2725163
    [Abstract] [Full Text] [Related]

  • 55. [Clinical studies of S6472 in otorhinolaryngologic infections].
    Baba S, Kinoshita H, Mori Y, Suzuki K, Ohyama M, Katsuta K, Furuta S, Ohno I, Noboru T, Yamamoto M.
    Jpn J Antibiot; 1985 Jul 30; 38(7):1750-60. PubMed ID: 4068219
    [Abstract] [Full Text] [Related]

  • 56. Three-day and seven-day treatment in acute otitis media: a double-blind antibiotic trial.
    Jones R, Bain J.
    J R Coll Gen Pract; 1986 Aug 30; 36(289):356-8. PubMed ID: 3735223
    [Abstract] [Full Text] [Related]

  • 57. [New oral cephem antibiotic, cefroxadine capsules, against superficial suppurative disease in the field of surgery].
    Abe N, Sakurai K.
    Jpn J Antibiot; 1983 Sep 30; 36(9):2515-20. PubMed ID: 6655866
    [Abstract] [Full Text] [Related]

  • 58. [Clinical evaluation of cefroxadine in surgical infections].
    Hirayama T, Kikuchi K.
    Jpn J Antibiot; 1983 Jun 30; 36(6):1435-8. PubMed ID: 6655799
    [Abstract] [Full Text] [Related]

  • 59. [The clinical investigation of bacteriology of chronic suppurative otitis media].
    Yang Y, Gong S, Liu Y.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Dec 30; 15(12):550-2. PubMed ID: 12541726
    [Abstract] [Full Text] [Related]

  • 60. [Clinical experience with cefroxadine in bacterial infection of children (author's transl)].
    Sekiguchi T, Hosoda T, Ichioka T, Miyao M, Kokawa T, Uyama Y, Tanaka H.
    Jpn J Antibiot; 1981 Dec 30; 34(12):1691-6. PubMed ID: 7334593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.